Search results for

Conducting opposition proceedings at OHIM is full of pitfalls for the uninitiated. Tasneem Haq provides 10 rules to help trade mark owners achieve success

A series of innovative yet controversial television commercials in New Zealand promoting Roche's weight management product XENICAL have won the 2000 prestigious Television New Zealand/Marketing Magazine Supreme Award.

BT is to launch a major licensing push in the US and Canada to exploit value from its 14,000 patents. James Nurton visits the telecoms company’s global research headquarters near Ipswich, England to find out how

Anti-counterfeiting agencies have scored some major victories against copyright pirates in the UK. But enforcement remains an uphill struggle, as Ingrid Hering reports

The US is ready to take punitive action against Ukraine, if the eastern European country does not clamp down on copyright pirates immediately.

To a packed courtroom on Thursday April 19, 39 drug companies agreed to drop their lawsuit against the South African government.

John A Tessensohn and Shusaku Yamamoto, of Shusaku Yamamoto in Osaka, examine the different strategic options for enforcing patent rights in Japan

In one of the most eagerly-awaited patent trials in recent years, Amgen has successfully defended three out of the five patents protecting its best-selling drug Epogen. In a 245-page ruling, Judge William G Young of the US District Court in Boston ruled that Transkaryotic Therapies (TKT) infringed the patents in its experimental drug Dynepo. But he ruled that two further patents on Epogen were not infringed. Dynepo is at present in phase III clinical trials. TKT´ s shares fell over 50% following the decision, while Amgen´ s share price shot up 10%.

An action to revoke its patent on the drug Videx EC threatens to limit further Bristol-Myers Squibb's (BMS) rights to sell Aids medicines in Thailand. Three Aids patients and the Foundation for Consumers, a local group, claim that the US pharmaceutical company did not invent the drug and so should not be allowed to own the rights to it in Thailand. According to the plaintiffs, the drug is a product of collaboration between BMS and the US National Institutes of Health (NIH).

The USPTO wants to make it mandatory to file trade mark applications electronically. Colleen Connors Butler of Brinks Hofer Gilson & Lione reveals the advantages and disadvantages of doing so